Skip to main content
. 2018 Oct 11;144(12):1116–1124. doi: 10.1001/jamaoto.2018.1919

Table 2. Potentially Confounding Covariates in 293 Participantsa.

Variable No. (%) Effect Size (95% CI)
Ever PPI (n = 149) Never PPI (n = 144)
Demographics
Male sex 87 (58.4) 90 (62.5) 0.84 (0.53 to 1.35)
Premature 51 (34.2) 49 (34.0) 1.01 (0.62 to 1.64)
Age at first VFSS, mean (SE), mo 8.1 (0.5) 9.2 (0.6) 0.16 (−0.07 to 0.39)
Comorbidities
Feeding tube 49 (32.9) 33 (22.9) 1.65 (0.98 to 2.77)
Neurologic 39 (26.2) 51 (35.4) 0.65 (0.39 to 1.07)
Cardiac 19 (12.8) 14 (9.7) 1.36 (0.65 to 2.82)
Metabolic 18 (12.2) 19 (13.2) 0.91 (0.46 to 1.82)
Symptoms
Symptoms during meals 114 (76.5) 106 (73.6) 1.17 (0.69 to 1.98)
Symptoms after meals 56 (37.6) 27 (18.8) 2.61 (1.53 to 4.45)
Vomiting 48 (32.2) 24 (16.7) 2.38 (1.36 to 4.15)
Coughing 84 (56.4) 89 (61.8) 0.80 (0.50 to 1.27)
Congestion 32 (21.5) 26 (18.1) 1.24 (0.70 to 2.21)
Eyes watering 2 (1.3) 1 (0.7) 1.95 (0.17 to 21.69)
Noisy breathing 40 (26.9) 41 (28.5) 0.92 (0.55 to 1.54)
Increased work of breathing 19 (12.8) 19 (13.2) 0.96 (0.49 to 1.90)
Choking or gagging 61 (40.9) 51 (35.4) 1.26 (0.79 to 2.03)
Slow feeding 14 (9.4) 2 (1.4) 7.36 (1.64 to 33.01)
Poor feeding 35 (23.5) 28 (19.4) 1.27 (0.73 to 2.23)
Oxygen requirement 5 (3.4) 11 (7.6) 0.42 (0.14 to 1.24)
Spells 27 (18.1) 26 (18.1) 1.00 (0.55 to 1.82)
Pneumonia 20 (13.4) 14 (9.7) 1.44 (0.70 to 2.97)

Abbreviations: PPI, proton pump inhibitor; SE, standard error; VFSS, videofluoroscopic swallow study.

a

Data are expressed as No. (percentage) or mean (SE) with effect size expressed as odds ratio or Cohen’s d, respectively. Demographic variables and comorbidities were balanced between the two groups with no significant differences.